ALXO — ALX ONCOLOGY HLDGS INC

Ownership history in Abel Hall, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Abel Hall, LLC reported a position in ALX ONCOLOGY HLDGS INC (ALXO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.01%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 12,598 — 0% 0.00% $14K $1.13
2025 Q3 REDUCED 12,598 -2,611 -17.2% 0.01% $23K $1.83
2025 Q2 ADDED 15,209 +4,803 +46.2% 0.00% $6K $0.41
2024 Q4 INITIATED 10,406 — — 0.01% $17K $1.67
% of Fund (quarterly)    ALXO price (monthly, adj. close)

Other funds also holding ALXO

As of 2025 Q4 — sorted by position size

venBio Partners LLC 3Y 5.07% Almitas Capital LLC 3Y 7Y 0.63% Redmile Group, LLC 3Y 7Y 0.27% Seven Fleet Capital Management LP 0.1% HC Advisors, LLC 3Y 0.02% DRIEHAUS CAPITAL MANAGEMENT LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% JSF Financial, LLC 3Y 0.0% NAN FUNG TRINITY (HK) Ltd 3Y 0.0% NINE MASTS CAPITAL Ltd 3Y 7Y 0.0%
← Back to Abel Hall, LLC Holdings